logo

For the Inventor, By the Inventor

Laguna Hills, CA, United States of America

Glaukos Corporation


USPTO Granted Patents = 121

% Expired Patents = 11.6



Forward Citations = 10,004

Loading Chart...
Loading Chart...

62 inventors (with patents filed for the assignee):

goldMedal David S Haffner (73 out of 95 patents)

silverMedal Hosheng Tu (34 out of 153 patents)

bronzeMedal Gregory T Smedley (33 out of 38 patents)

4.  Charles Raymond Kalina, Jr (26 out of 27 patents)

5.  Thomas W Burns (26 out of 35 patents)

6.  Barbara A Niksch (23 out of 26 patents)

7.  Olav B Bergheim (18 out of 22 patents)

8.  Harold Alexander Heitzmann (15 out of 36 patents)

9.  Morteza Gharib (13 out of 144 patents)

10.  Kenneth Martin Curry (11 out of 35 patents)

11.  Douglas Daniel Crimaldi (10 out of 11 patents)

12.  Todd N Fjield (9 out of 21 patents)

13.  Richard A Hill (9 out of 20 patents)

14.  Henrick K Gille (8 out of 11 patents)

15.  Reay H Brown (8 out of 20 patents)


Core Competencies:
Glaucoma Stent
Drug Delivery
Intraocular Sensor
Ocular Implants
Gonioscopic Devices
Punctal Implants
Uveoscleral Shunt
Fluid Infusion
Therapeutic Agent
Implant Delivery
Ocular Disorder Treatment
Drug-Eluting Implants

121 patents:

1. 12702294 - Gonioscopes (2026-08-11),
2. D1137672 - Drug eluting ocular implant (2026-07-28),
3. 12667486 - Bioresorbable ocular drug delivery device (2026-06-30),
4. 12667312 - Intraocular physiological sensor (2026-06-30),
5. 12667269 - Intraocular physiological sensor (2026-06-30),
6. 12599497 - Implants with controlled drug delivery features and methods of using same (2026-04-14),
7. 12575972 - Glaucoma stent and methods thereof for glaucoma treatment (2026-03-17),
8. 12533344 - Formulations (2026-01-27),
9. 12478504 - Drug eluting ocular implants (2025-11-25),
10. 12478503 - Implants with controlled drug delivery features and methods of using same (2025-11-25),
11. 12453653 - Materials and methods for punctal plugs (2025-10-28),
12. 12427057 - Controlled drug delivery ocular implants and methods of using same (2025-09-30),
13. 12419783 - Drug eluting ocular implant (2025-09-23),
14. 12414938 - Ophthalmic topical cream compositions and methods (2025-09-16),
15. 12414798 - Systems and methods for delivering multiple ocular implants (2025-09-16),
Glaukos Corporation, headquartered in Laguna Hills, California, specializes in innovative ocular implants aimed at treating glaucoma and other eye conditions. The company focuses on developing advanced technologies such as glaucoma stents, drug delivery systems, and intraocular sensors. Their product portfolio includes gonioscopic devices, punctal implants, and uveoscleral shunts, all designed to enhance patient outcomes and improve the management of ocular diseases. Glaukos is committed to pioneering solutions that address unmet medical needs in the field of ophthalmology.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Glaukos Corporation
121 Patents

#2 in Laguna Hills, CA

#720 in California

#3,196 in US

#6,604 in the World

Laguna Hills, CA (US)
Laguna Hills, CA, United States of America

Glaukos Corporation

Forward Citations = 10,004

62 inventors:

goldMedal David S Haffner (73 out of 95 patents)

silverMedal Hosheng Tu (34 out of 153 patents)

bronzeMedal Gregory T Smedley (33 out of 38 patents)

4.  Charles Raymond Kalina, Jr (26 out of 27 patents)

5.  Thomas W Burns (26 out of 35 patents)

Please report any incorrect information to [email protected]
Loading…